Delivery Order SPE2DE21D7020-SPE2D625F7NX7
- Not listed
- This is a $37,050 fixed-price with economic price adjustment delivery order contract awarded to Boston Scientific Corp by the Defense Logistics Agency (DLA) for the supply of drug-coated balloons, which are a type of medical device used in cardiovascular procedures. The contract has a performance period that extends to May 2024. Boston Scientific, a leading manufacturer of medical technologies, has been providing a wide range of innovative medical devices and services to federal healthcare...
- This is a $8,106.16 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company, for the provision of an AGENT DRUG COATED BALLOON. The contract has an ultimate completion date of May 20, 2025. Boston Scientific is a manufacturer of advanced medical devices and equipment, and this award supports the company's role as a specialized supplier of sophisticated medical technologies to federal healthcare agencies,...
- This is a $37,072.97 firm-fixed price with economic price adjustment delivery order awarded to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency's Medical Supply Chain. The contract is for the delivery of AGENT drug-coated balloons, a specialized medical device used for cardiovascular procedures. Boston Scientific is a key supplier of advanced medical equipment and implants to federal healthcare agencies, including the Department of Veterans Affairs and...
- The U.S. Department of Defense's Medical Supply Chain awarded a $12,100.60 fixed-price delivery order contract to Boston Scientific Corp, a leading medical device manufacturer, for the supply of an "AGENT DRUG COATED BALLOON" product. This contract is not associated with a set-aside program. The award is under a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle, as Boston Scientific has received multiple delivery orders from the Defense Logistics Agency (DLA) and...
- This is a $38,250.46 fixed-price delivery order contract awarded to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency's Medical Supply Chain. The contract is for the provision of agent drug coated balloons, a specialized medical device used in vascular procedures. The contract has an ultimate completion date of June 3, 2025 and does not have a set-aside designation, indicating Boston Scientific competed for this award on the open market. Boston...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the delivery of an "AGENT DRUG COATED BALLOON" medical device. The $24,898.52 fixed-price with economic price adjustment contract has a performance period ending on May 20, 2025. The contract is not set aside for any specific business type. Boston Scientific Corp is the prime contractor, and the place of performance is Marlborough, MA. This award...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company. The contract, valued at $18,619.40, is for the delivery of drug-coated balloons, which are specialized medical devices used in cardiovascular procedures. The contract has an ultimate completion date of February 14, 2025. The contract is not set-aside and represents an order under a larger indefinite delivery/indefinite quantity...
- This is a $6,175 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp for the delivery of Drug Coated Balloons. The contract has a period of performance ending on September 12, 2024. Boston Scientific, a leading medical device manufacturer, will provide these specialized balloons to support federal healthcare initiatives, particularly for the Department of Veterans Affairs (VA) and Department of Defense (DoD). The contract is not set aside...
- This is a federal contract award to Boston Scientific Corp, a global medical technology company, by the Defense Health Agency (DHA) for the supply of an "AGENT DRUG COATED BALLOON" medical device. The fixed-price contract with economic price adjustment has a ceiling value of $11,495.24 and a completion date of June 23, 2025. The contract is not set aside for any specific business type. Boston Scientific is the prime contractor and sole provider under this delivery order contract, which...
- This is a fixed-price delivery order awarded by the Medical Supply Chain, a defense agency within the Department of Defense, to Boston Scientific Corp. The contract is for the supply of a drug-coated balloon medical device, with a ceiling value of $37,050 and a period of performance ending on May 29, 2024. Boston Scientific, a leading manufacturer of medical devices, is the prime contractor for this award, which is not set aside. The award appears to be part of a larger indefinite...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F7NX7Delivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing procurement of specialized cardiovascular medical devices by the federal government through its established vendor relationships. This delivery order operates within Boston Scientific's broader portfolio of federal healthcare contracts, where the company serves as a primary supplier of advanced medical technologies to agencies including the Defense Health Agency and Department of Veterans Affairs. The company's expertise in interventional cardiology, demonstrated through previous awards for stents, catheters, and other cardiovascular intervention tools, positions it as a critical component of the federal medical supply chain. The drug-coated balloon delivery under this contract supports the Defense Health Agency's mission to provide cutting-edge cardiovascular treatment capabilities to military health system beneficiaries and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 7/18/25 |